mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.06 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.07 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.07 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.07 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.07 |